EFFECTIVENESS AND SAFETY OF APIXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION ENROLLED IN MEDICARE AND VETERAN AFFAIRS

被引：0
|
作者：
Deitelzweig, Steven Bruce
Sah, Janvi
Kang, Amiee
Russ, Cristina
Preib, Madison
Dhamane, Amol
Ratiu, Anna
Cato, Matthew
Alfred, Tamuno
Levi, Edi
Di Fusco, Manuela
机构：
[1] Pfizer Inc, New York, NY USA
[2] Bristol Myers Squibb Co, Lawrenceville, NJ USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1593 / 1593
页数：1
相关论文
共 50 条
  • [1] Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs
    Deitelzweig, Steve
    Sah, Janvi
    Kang, Amiee
    Russ, Cristina
    Preib, Madison
    Dhamane, Amol D.
    Ratiu, Anna
    Cato, Matthew
    Alfred, Tamuno
    Levi, Edi
    Di Fusco, Manuela
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2022, 163 : 43 - 49
  • [2] Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
    Yao, Xiaoxi
    Abraham, Neena S.
    Sangaralingham, Lindsey R.
    Bellolio, M. Fernanda
    McBane, Robert D.
    Shah, Nilay D.
    Noseworthy, Peter A.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06):
  • [3] EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: ARISTOPHANES SUBGROUP ANALYSIS
    Deitelzweig, Steven
    Keshishian, Allison
    Kang, Amiee
    Dhamane, Amol
    Luo, Xuemei
    Li, Xiaoyan
    Balachander, Neeraja
    Rosenblatt, Lisa
    Mardekian, Jack
    Pan, Xianying
    Di Fusco, Manuela
    Garcia, Alessandra Bassalobre
    Yuce, Huseyin
    Lip, Gregory Y. H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 435 - 435
  • [4] Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
    Martinez, Brandon K.
    Sood, Nitesh A.
    Bunz, Thomas J.
    Coleman, Craig I.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
  • [5] EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN FRAIL PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
    Coleman, Craig I.
    Turpie, Alexander
    Bunz, Thomas J.
    Sood, Nitesh
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 290 - 290
  • [6] CKD Progression in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation Treatead with Apixaban Versus Warfarin
    Wetmore, James B.
    Yan, Heng
    Herzog, Charles A.
    Weinhandl, Eric
    Reyes, Jorge L.
    Roetker, Nicholas S.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (02) : 180 - 189
  • [7] Effectiveness and Safety of Apixaban and Rivaroxaban Versus Warfarin for the Secondary Prevention of Stroke or Systemic Embolism Among Nonvalvular Atrial Fibrillation Patients
    Coleman, Craig
    Bunz, Thomas
    [J]. NEUROLOGY, 2017, 88
  • [8] Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack
    Coleman, Craig I.
    Peacock, W. Frank
    Bunz, Thomas J.
    Alberts, Mark J.
    [J]. STROKE, 2017, 48 (08) : 2142 - +
  • [9] Safety and Effectiveness of Apixaban Versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation Stratified by Renal Function: A Retrospective Cohort Study
    Morimoto, Takeshi
    Hoshino, Haruhiko
    Matsuo, Yukako
    Ibuki, Tatsuki
    Miyata, Kayoko
    Koretsune, Yukihiro
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (06) : 721 - 733
  • [10] EFFECTIVENESS AND SAFETY OF APIXABAN AND RIVAROXABAN VERSUS WARFARIN FOR THE SECONDARY PREVENTION OF STROKE OR SYSTEMIC EMBOLISM AMONG NONVALVULAR ATRIAL FIBRILLATION PATIENTS
    Coleman, Craig I.
    Bunz, Thomas J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 458 - 458
12345